ANXA5 and melanoma: We treated VR melanoma cells with palbociclib for 8 days and cultured them with medium lacking glutamine for an additional 3 days to assess cell death by Annexin V. We demonstrated that, unlike CB-839, glutamine depletion did not provoke senolysis in palbociclib-induced senescent cells (Fig. 4D).